Navigating α‐Synuclein Aggregation Inhibition: Methods, Mechanisms, and Molecular Targets
出版年份 2023 全文链接
标题
Navigating α‐Synuclein Aggregation Inhibition: Methods, Mechanisms, and Molecular Targets
作者
关键词
-
出版物
CHEMICAL RECORD
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-11-03
DOI
10.1002/tcr.202300282
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacological characterization of the small molecule 03A10 as an inhibitor of α-synuclein aggregation for Parkinson’s disease treatment
- (2023) Qing Wang et al. ACTA PHARMACOLOGICA SINICA
- Dopamine-Induced Oligomers of α-Synuclein Inhibit Amyloid Fibril Growth and Show No Toxicity
- (2023) Maksym Galkin et al. ACS Chemical Neuroscience
- Discerning Modulation of α-Synuclein Amyloid Assembly by α-Crystallin
- (2023) Bhumika Pippal et al. ACS Chemical Neuroscience
- Small molecule-based fluorescent probes for the detection of α-Synuclein aggregation states
- (2023) Rajibul Haque et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Advanced human iPSC-based preclinical model for Parkinson’s disease with optogenetic alpha-synuclein aggregation
- (2023) Min Seong Kim et al. Cell Stem Cell
- A RaPID Macrocyclic Peptide That Inhibits the Formation of α‐Synuclein Amyloid Fibrils
- (2023) Tatsuya Ikenoue et al. CHEMBIOCHEM
- Discovery of Small-Molecule Degraders for Alpha-Synuclein Aggregates
- (2023) Yichen Tong et al. Journal of Medicinal Chemistry
- Quantitative Seed Amplification Assay: A Proof-of-Principle Study
- (2023) Jonathan Vaneyck et al. Journal of Physical Chemistry B
- Optimization of a small molecule inhibitor of secondary nucleation in α-synuclein aggregation
- (2023) Roxine Staats et al. Frontiers in Molecular Biosciences
- In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson’s disease
- (2023) Diana L. Price et al. npj Parkinsons Disease
- Stability matters, too - The thermodynamics of amyloid fibril formation
- (2022) Alexander Buell Chemical Science
- Monitoring the interactions between alpha-synuclein and Tau in vitro and in vivo using bimolecular fluorescence complementation
- (2022) Laura Torres-Garcia et al. Scientific Reports
- The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple α-synuclein strains
- (2022) Samuel Peña-Díaz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Effect of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study
- (2022) Vincenzo Donadio et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity
- (2022) Simona S. Ghanem et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanofibrous materials affect the reaction of cytotoxicity assays
- (2022) Rafał Podgórski et al. Scientific Reports
- Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial
- (2022) Johannes Levin et al. EBioMedicine
- Rationally designed amyloid inhibitors based on amyloid-related structural studies
- (2022) Jinjian Hu et al. CHINESE CHEMICAL LETTERS
- De novo designed protein inhibitors of amyloid aggregation and seeding
- (2022) Kevin A. Murray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blots on a field?
- (2022) Charles Piller SCIENCE
- Curcumin Interacts with α-Synuclein Condensates To Inhibit Amyloid Aggregation under Phase Separation
- (2022) Bingkuan Xu et al. ACS Omega
- Modulation of α-Synuclein Aggregation In Vitro by a DNA Aptamer
- (2022) Claire H. Tran et al. BIOCHEMISTRY
- Designer D-peptides targeting the N-terminal region of α-synuclein to prevent parkinsonian-associated fibrilization and cytotoxicity
- (2022) John R. Horsley et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model
- (2022) Tony S. Eteläinen et al. NEUROPHARMACOLOGY
- The clinical drug candidate anle138b binds in a cavity of lipidic α-synuclein fibrils
- (2022) Leif Antonschmidt et al. Nature Communications
- Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson’s disease
- (2022) Can Cui et al. Frontiers in Cellular and Infection Microbiology
- Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease
- (2022) Yumin Wang et al. Frontiers in Pharmacology
- Structure-Based Discovery of Small-Molecule Inhibitors of the Autocatalytic Proliferation of α-Synuclein Aggregates
- (2022) Sean Chia et al. Molecular Pharmaceutics
- Monitoring α-synuclein aggregation
- (2022) Juan Estaun-Panzano et al. NEUROBIOLOGY OF DISEASE
- Quercetin Is An Active Agent in Berries against Neurodegenerative Diseases Progression through Modulation of Nrf2/HO1
- (2022) Al Borhan Bayazid et al. Nutrients
- Influence of Lipid Membranes on α-Synuclein Aggregation
- (2021) Andrii S. Kurochka et al. ACS Chemical Neuroscience
- Fluorescent Probe for Selective Imaging of α-Synuclein Fibrils in Living Cells
- (2021) Pankaj Gaur et al. ACS Chemical Neuroscience
- Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice
- (2021) Rubén Pavia-Collado et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rationally Designed Protein-Based Inhibitor of α-Synuclein Fibrillization in Cells
- (2021) Anastasiia Priss et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Two Novel Peptides That Inhibit α-Synuclein Toxicity and Aggregation
- (2021) Blagovesta Popova et al. Frontiers in Molecular Neuroscience
- Pentameric Thiophene as a Probe to Monitor EGCG’s Remodeling Activity of Mature Amyloid Fibrils: Overcoming Signal Artifacts of Thioflavin T
- (2021) Mirian Kelley et al. ACS Omega
- Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids
- (2021) Dieter Willbold et al. CHEMICAL REVIEWS
- Potential protective mechanisms of green tea polyphenol EGCG against COVID-19
- (2021) Zhichao Zhang et al. TRENDS IN FOOD SCIENCE & TECHNOLOGY
- α-Helical peptidic scaffolds to target α-synuclein toxic species with nanomolar affinity
- (2021) Jaime Santos et al. Nature Communications
- Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders
- (2021) Nelson de Oliveira Manzanza et al. Frontiers in Aging Neuroscience
- A β-Wrapin Targeting the N-Terminus of α-Synuclein Monomers Reduces Fibril-Induced Aggregation in Neurons
- (2021) Éva M. Szegő et al. Frontiers in Neuroscience
- Green Tea Polyphenol Epigallocatechin-Gallate in Amyloid Aggregation and Neurodegenerative Diseases
- (2021) Luiza Fernandes et al. Frontiers in Neuroscience
- α-Synuclein: An All-Inclusive Trip Around its Structure, Influencing Factors and Applied Techniques
- (2021) Nicolò Bisi et al. Frontiers in Chemistry
- Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
- (2021) Luis M. A. Oliveira et al. npj Parkinsons Disease
- Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensors
- (2021) Anthony R. Braun et al. npj Parkinsons Disease
- Design, synthesis and structure-activity evaluation of novel 2-pyridone-based inhibitors of α-synuclein aggregation with potentially improved BBB permeability
- (2021) Alejandro Mahía et al. BIOORGANIC CHEMISTRY
- FRET‐based assay for intracellular evaluation of α‐synuclein aggregation inhibitors
- (2021) Maksym Galkin et al. JOURNAL OF NEUROCHEMISTRY
- One ring is sufficient to inhibit α-synuclein aggregation
- (2021) Salvador Ventura et al. Neural Regeneration Research
- The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril ends
- (2021) Matthias M. Schneider et al. Nature Communications
- Inhibition of synucleinopathic seeding by rationally designed inhibitors
- (2020) Smriti Sangwan et al. eLife
- Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles
- (2020) Luis D. Bernal-Conde et al. Frontiers in Neuroscience
- The Influence of Pathogenic Mutations in α-Synuclein on Biophysical and Structural Characteristics of Amyloid Fibrils
- (2020) Francesco Simone Ruggeri et al. ACS Nano
- Cryo-EM structure of full-length α-synuclein amyloid fibril with Parkinson’s disease familial A53T mutation
- (2020) Yunpeng Sun et al. CELL RESEARCH
- New insights on the structure of alpha-synuclein fibrils using cryo-electron microscopy
- (2020) Ricardo Guerrero-Ferreira et al. CURRENT OPINION IN NEUROBIOLOGY
- The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of α-Synuclein Amyloid Fibril Formation
- (2020) Rebecca Sternke-Hoffmann et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Novel Furan-2-yl-1H-pyrazoles Possess Inhibitory Activity against α-Synuclein Aggregation
- (2020) Philip Ryan et al. ACS Chemical Neuroscience
- Vesicle trafficking and lipid metabolism in synucleinopathy
- (2020) Saranna Fanning et al. ACTA NEUROPATHOLOGICA
- Monitoring alpha‐synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: what you see is not always what you get
- (2020) Bryan Frey et al. JOURNAL OF NEUROCHEMISTRY
- Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
- (2020) Antonio Dominguez-Meijide et al. Scientific Reports
- Alpha-Synuclein FRET Biosensors Reveal Early Alpha-Synuclein Aggregation in the Endoplasmic Reticulum
- (2020) Fabiana Miraglia et al. Life-Basel
- Potential Role of Natural Polyphenols against Protein Aggregation Toxicity: In Vitro, In Vivo, and Clinical Studies
- (2020) Gabriela Henríquez et al. ACS Chemical Neuroscience
- Inhibitors of α-Synuclein Fibrillation and Oligomer Toxicity in Rosa damascena: The All-Pervading Powers of Flavonoids and Phenolic Glycosides
- (2020) Hoda Eskandari et al. ACS Chemical Neuroscience
- Naphthoquinone‐Dopamine hybrids inhibit α‐synuclein aggregation, disrupt preformed fibrils and attenuate aggregate‐induced toxicity
- (2020) Ashim Paul et al. CHEMISTRY-A EUROPEAN JOURNAL
- A Comparative Photophysical Study of Structural Modifications of Thioflavin T-Inspired Fluorophores
- (2020) Lisa-Maria Needham et al. Journal of Physical Chemistry Letters
- On the reliability of highly magnified micrographs for structural analysis in materials science
- (2020) Martin Wortmann et al. Scientific Reports
- Novel self-replicating α-synuclein polymorphs that escape ThT monitoring can spontaneously emerge and acutely spread in neurons
- (2020) Francesca De Giorgi et al. Science Advances
- Inhibition of α-Synuclein Aggregation and Mature Fibril Disassembling With a Minimalistic Compound, ZPDm
- (2020) Samuel Peña-Díaz et al. Frontiers in Bioengineering and Biotechnology
- Interactions of α-synuclein oligomers with lipid membranes
- (2020) Greta Musteikytė et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Long-term RNAi knockdown of α-synuclein in the adult rat substantia nigra without neurodegeneration
- (2019) Alevtina Zharikov et al. NEUROBIOLOGY OF DISEASE
- Designing a rigorous microscopy experiment: Validating methods and avoiding bias
- (2019) Anna Payne-Tobin Jost et al. JOURNAL OF CELL BIOLOGY
- Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation
- (2019) Valentina Oliveri EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Lipids at the Crossroad of α-Synuclein Function and Dysfunction: Biological and Pathological Implications
- (2019) Natalia P. Alza et al. Frontiers in Cellular Neuroscience
- Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
- (2019) Irina Alecu et al. Frontiers in Neuroscience
- α-Synuclein aggregation at low concentrations
- (2019) Kseniia Afitska et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- The physiological role of α‐synuclein and its relationship to Parkinson’s Disease
- (2019) David Sulzer et al. JOURNAL OF NEUROCHEMISTRY
- α‐synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities
- (2019) Parvez Alam et al. JOURNAL OF NEUROCHEMISTRY
- An engineered monomer binding-protein for α-synuclein efficiently inhibits the proliferation of amyloid fibrils
- (2019) Emil Dandanell Agerschou et al. eLife
- α-Synuclein Dimers as Potent Inhibitors of Fibrillization
- (2019) Yevhenii A. Kyriukha et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs
- (2019) David R. Boyer et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Different Heat Shock Proteins Bind α-Synuclein With Distinct Mechanisms and Synergistically Prevent Its Amyloid Aggregation
- (2019) Chunyu Jia et al. Frontiers in Neuroscience
- Structural Optimization of Inhibitors of α-Synuclein Fibril Growth: Affinity to the Fibril End as a Crucial Factor
- (2019) Kseniia Afitska et al. JOURNAL OF MOLECULAR BIOLOGY
- Immunotherapy in Parkinson’s disease: Current status and future directions
- (2019) Diptaman Chatterjee et al. NEUROBIOLOGY OF DISEASE
- Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy
- (2019) Ricardo Guerrero-Ferreira et al. eLife
- ZPD-2, a Small Compound That Inhibits α-Synuclein Amyloid Aggregation and Its Seeded Polymerization
- (2019) Samuel Peña-Díaz et al. Frontiers in Molecular Neuroscience
- Inhibition of α-Synuclein Amyloid Fibril Elongation by Blocking Fibril Ends
- (2018) Volodymyr V. Shvadchak et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Photophysics of diphenyl-pyrazole compounds in solutions and α-synuclein aggregates
- (2018) Anne M. Reiner et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Secondary nucleation in amyloid formation
- (2018) Mattias Törnquist et al. CHEMICAL COMMUNICATIONS
- Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases
- (2018) Qian Yi Eng et al. JOURNAL OF ETHNOPHARMACOLOGY
- Different Conformational Subensembles of the Intrinsically Disordered Protein α-Synuclein in Cells
- (2018) Mohammad A. A. Fakhree et al. Journal of Physical Chemistry Letters
- Cryo-EM structure of alpha-synuclein fibrils
- (2018) Ricardo Guerrero-Ferreira et al. eLife
- Novel DNA Aptamers for Parkinson’s Disease Treatment Inhibit α-Synuclein Aggregation and Facilitate its Degradation
- (2018) Yuan Zheng et al. Molecular Therapy-Nucleic Acids
- Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice
- (2018) Waijiao Cai et al. EBioMedicine
- Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy
- (2018) Yaowang Li et al. CELL RESEARCH
- Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD
- (2018) Boris Kantor et al. MOLECULAR THERAPY
- Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons
- (2018) Jordi Pujols et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel
- (2018) Binsen Li et al. Nature Communications
- The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease
- (2018) Diana L. Price et al. Scientific Reports
- Anle138b modulates α-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy
- (2018) Antonio Heras-Garvin et al. MOVEMENT DISORDERS
- The Essential Medicinal Chemistry of Curcumin
- (2017) Kathryn M. Nelson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Opposed Effects of Dityrosine Formation in Soluble and Aggregated α-Synuclein on Fibril Growth
- (2017) Michael M. Wördehoff et al. JOURNAL OF MOLECULAR BIOLOGY
- C-Terminal Truncated α-Synuclein Fibrils Contain Strongly Twisted β-Sheets
- (2017) Aditya Iyer et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The future burden of Parkinson's disease
- (2017) Walter A. Rocca MOVEMENT DISORDERS
- A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein
- (2017) Franziska Richter et al. Neurotherapeutics
- The Synucleinopathies: Twenty Years On
- (2017) Michel Goedert et al. Journal of Parkinsons Disease
- Synucleins and Gene Expression: Ramblers in a Crowd or Cops Regulating Traffic?
- (2017) Alexei A. Surguchev et al. Frontiers in Molecular Neuroscience
- Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments
- (2017) Panchanan Maiti et al. Translational Neurodegeneration
- EGCG-mediated Protection of the Membrane Disruption and Cytotoxicity Caused by the ‘Active Oligomer’ of α-Synuclein
- (2017) Jee Eun Yang et al. Scientific Reports
- Opposite Structural Effects of Epigallocatechin-3-gallate and Dopamine Binding to α-Synuclein
- (2016) Albert Konijnenberg et al. ANALYTICAL CHEMISTRY
- Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity
- (2016) Huy T. Lam et al. BIOCHEMISTRY
- Ade novocompound targeting α-synuclein improves deficits in models of Parkinson’s disease
- (2016) Wolfgang Wrasidlo et al. BRAIN
- Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
- (2016) David S. Hersh et al. CURRENT PHARMACEUTICAL DESIGN
- Protocatechuic Acid: Inhibition of Fibril Formation, Destabilization of Preformed Fibrils of Amyloid-β and α-Synuclein, and Neuroprotection
- (2016) Ruth Hornedo-Ortega et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application
- (2016) Lingjia Xu et al. Parkinsons Disease
- Anle138b Partly Ameliorates Motor Deficits Despite Failure of Neuroprotection in a Model of Advanced Multiple System Atrophy
- (2016) Lisa Fellner et al. Frontiers in Neuroscience
- Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
- (2016) Lars Tatenhorst et al. Acta Neuropathologica Communications
- β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces
- (2016) James W. P. Brown et al. Scientific Reports
- Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation
- (2015) Eric Y. Hayden et al. BIOCHEMISTRY
- Anle138b and related compounds are aggregation specific fluorescence markers and reveal high affinity binding to α-synuclein aggregates
- (2015) Andreas A. Deeg et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Understanding FRET as a Research Tool for Cellular Studies
- (2015) Dilip Shrestha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Intracellular Screening of a Peptide Library to Derive a Potent Peptide Inhibitor of α-Synuclein Aggregation
- (2015) Harish Cheruvara et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- α-Synuclein Amyloid Fibrils with Two Entwined, Asymmetrically Associated Protofibrils
- (2015) Altaira D. Dearborn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization
- (2015) Filsy Samuel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibril Breaking Accelerates α-Synuclein Fibrillization
- (2015) Volodymyr V. Shvadchak et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation
- (2015) Céline Galvagnion et al. Nature Chemical Biology
- Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys
- (2015) M. Chen et al. NEUROSCIENCE
- Ferulic acid pretreatment mitigates MPTP-induced motor impairment and histopathological alterations in C57BL/6 mice
- (2015) Sangeetha Nagarajan et al. PHARMACEUTICAL BIOLOGY
- Curcumin Treatment Improves Motor Behavior in α-Synuclein Transgenic Mice
- (2015) Kateri J. Spinelli et al. PLoS One
- Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein
- (2015) Nuzhat Ahsan et al. Scientific Reports
- The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset
- (2014) Johannes Levin et al. ACTA NEUROPATHOLOGICA
- Sequestration of a β-Hairpin for Control of α-Synuclein Aggregation
- (2014) Ewa A. Mirecka et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Hemin as a generic and potent protein misfolding inhibitor
- (2014) Yanqin Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- β-Cyclodextrin and Curcumin, a Potent Cocktail for Disaggregating and/or Inhibiting Amyloids: A Case Study with α-Synuclein
- (2014) Saurabh Gautam et al. BIOCHEMISTRY
- Purification of α-Synuclein from Human Brain Reveals an Instability of Endogenous Multimers as the Protein Approaches Purity
- (2014) Eric S. Luth et al. BIOCHEMISTRY
- Genetic Insights into Sporadic Parkinson's Disease Pathogenesis
- (2014) Chou Chai et al. CURRENT GENOMICS
- Molecular Basis for Preventing α-Synuclein Aggregation by a Molecular Tweezer
- (2014) Srabasti Acharya et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- How Epigallocatechin Gallate Can Inhibit α-Synuclein Oligomer Toxicityin Vitro
- (2014) Nikolai Lorenzen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Solution conditions determine the relative importance of nucleation and growth processes in -synuclein aggregation
- (2014) A. K. Buell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins
- (2014) B. G. Wilhelm et al. SCIENCE
- Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity
- (2014) Mustafa T. Ardah et al. Frontiers in Aging Neuroscience
- Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease
- (2013) Jens Wagner et al. ACTA NEUROPATHOLOGICA
- Oxidized quercetin inhibits α-synuclein fibrillization
- (2013) Min Zhu et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration
- (2013) Maria Xilouri et al. BRAIN
- Prion-like spreading of pathological α-synuclein in brain
- (2013) Masami Masuda-Suzukake et al. BRAIN
- Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?
- (2013) Meihui Chen et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Toward the Molecular Mechanism(s) by Which EGCG Treatment Remodels Mature Amyloid Fibrils
- (2013) Fernando L. Palhano et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Direct Observation of Heterogeneous Amyloid Fibril Growth Kinetics via Two-Color Super-Resolution Microscopy
- (2013) Dorothea Pinotsi et al. NANO LETTERS
- Properties of native brain α-synuclein
- (2013) Jacqueline Burré et al. NATURE
- Update on novel familial forms of Parkinson's disease and multiple system atrophy
- (2013) Shinsuke Fujioka et al. PARKINSONISM & RELATED DISORDERS
- -Synuclein in Parkinson's Disease
- (2013) L. Stefanis Cold Spring Harbor Perspectives in Medicine
- Genetics of Parkinson's Disease
- (2013) C. Klein et al. Cold Spring Harbor Perspectives in Medicine
- Alternative Pathways of Human Islet Amyloid Polypeptide Aggregation Distinguished by 19F Nuclear Magnetic Resonance-Detected Kinetics of Monomer Consumption
- (2012) Yuta Suzuki et al. BIOCHEMISTRY
- Supramolecular Non-Amyloid Intermediates in the Early Stages of α-Synuclein Aggregation
- (2012) Jonathan A. Fauerbach et al. BIOPHYSICAL JOURNAL
- Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea
- (2012) J Steinmann et al. BRITISH JOURNAL OF PHARMACOLOGY
- Curcumin-glucoside, A Novel Synthetic Derivative of Curcumin, Inhibits α-Synuclein Oligomer Formation: Relevance to Parkinson's Disease
- (2012) Bharathi Shrikanth Gadad et al. CURRENT PHARMACEUTICAL DESIGN
- Effect of Quercetin in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease
- (2012) Chuanfeng Lv et al. Evidence-based Complementary and Alternative Medicine
- α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, andEscherichia coliExists Predominantly as Disordered Monomer
- (2012) Bruno Fauvet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Assessment of the treatment effect of baicalein on a model of Parkinsonian tremor and elucidation of the mechanism
- (2012) Xin Yu et al. LIFE SCIENCES
- A Novel “Molecular Tweezer” Inhibitor of α-Synuclein Neurotoxicity in Vitro and in Vivo
- (2012) Shubhangi Prabhudesai et al. Neurotherapeutics
- Pathological -Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
- (2012) K. C. Luk et al. SCIENCE
- Phosphorylated -Synuclein in Parkinson's Disease
- (2012) Y. Wang et al. Science Translational Medicine
- Drug therapy in patients with Parkinson’s disease
- (2012) Thomas Müller Translational Neurodegeneration
- Ion Mobility Mass Spectrometry Studies of the Inhibition of Alpha Synuclein Amyloid Fibril Formation by (–)-Epigallocatechin-3-Gallate
- (2011) Yanqin Liu et al. AUSTRALIAN JOURNAL OF CHEMISTRY
- PAMAM G4 dendrimers affect the aggregation of α-synuclein
- (2011) Katarzyna Milowska et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Hsc70 Protein Interaction with Soluble and Fibrillar α-Synuclein
- (2011) Samantha Pemberton et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Toward the Discovery of Effective Polycyclic Inhibitors of α-Synuclein Amyloid Assembly
- (2011) Gonzalo R. Lamberto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
- (2011) Tim Bartels et al. NATURE
- Prion-like acceleration of a synucleinopathy in a transgenic mouse model
- (2011) Anne-Laure Mougenot et al. NEUROBIOLOGY OF AGING
- Current approaches to the treatment of Parkinson’s disease
- (2011) Joseph Jankovic Neuropsychiatric Disease and Treatment
- The N-Terminus of the Intrinsically Disordered Protein α-Synuclein Triggers Membrane Binding and Helix Folding
- (2010) Tim Bartels et al. BIOPHYSICAL JOURNAL
- Entacapone and Tolcapone, Two CatecholO-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity
- (2010) Saviana Di Giovanni et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD Spectroscopy of Peptides and Proteins Bound to Large Unilamellar Vesicles
- (2010) Alexey S. Ladokhin et al. JOURNAL OF MEMBRANE BIOLOGY
- Inhibiting α-Synuclein Oligomerization by Stable Cell-Penetrating β-Synuclein Fragments Recovers Phenotype of Parkinson's Disease Model Flies
- (2010) Ronit Shaltiel-Karyo et al. PLoS One
- EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
- (2010) Jan Bieschke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- β-Sheet-breaking peptides inhibit the fibrillation of human α-synuclein
- (2009) You Soon Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds
- (2009) Sean A. Hudson et al. FEBS Journal
- Formation of dopamine-mediated α-synuclein-soluble oligomers requires methionine oxidation
- (2009) Su Ling Leong et al. FREE RADICAL BIOLOGY AND MEDICINE
- Dopamine and the Dopamine Oxidation Product 5,6-Dihydroxylindole Promote Distinct On-Pathway and Off-Pathway Aggregation of α-Synuclein in a pH-Dependent Manner
- (2009) Chi L.L. Pham et al. JOURNAL OF MOLECULAR BIOLOGY
- Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in -Synuclein Models of Parkinson's and Lewy Body Diseases
- (2009) B. Spencer et al. JOURNAL OF NEUROSCIENCE
- PAMAM Dendrimers as Potential Agents against Fibrillation ofα-Synuclein, a Parkinson's Disease-Related Protein
- (2009) Agata Rekas et al. MACROMOLECULAR BIOSCIENCE
- Genome-Wide Microarray Analysis of the Differential Neuroprotective Effects of Antioxidants in Neuroblastoma Cells Overexpressing the Familial Parkinson’s Disease α-Synuclein A53T Mutation
- (2009) Lei Ma et al. NEUROCHEMICAL RESEARCH
- Vinyl sulfone: a versatile function for simple bioconjugation and immobilization
- (2009) Julia Morales-Sanfrutos et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Structural and mechanistic basis behind the inhibitory interaction of PcTS on α-synuclein amyloid fibril formation
- (2009) Gonzalo R. Lamberto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Design of an N-Methylated Peptide Inhibitor of α-Synuclein Aggregation Guided by Solid-State NMR§
- (2008) Jillian Madine et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
- (2008) Dagmar E Ehrnhoefer et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The fold of -synuclein fibrils
- (2008) M. Vilar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson’s disease induced by MPTP neurodegeneration in mice
- (2008) A. Rajeswari et al. INFLAMMOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started